CellOrigin Biotech declared strategic world collaboration with Qilu Pharmaceutical to produce “off-the-shelf” Vehicle-iMAC cell therapy
HANGZHOU, China, Sept. 5, 2022 /PRNewswire/ -- CellOrigin Biotech (Hangzhou) Co., Ltd. declared that it has produced an settlement with Qilu...